Protagonist Therapeutics Other Long Term Liabilities (Quarterly) Analysis

Protagonist Therapeutics, Inc. (PTGX)

84.51 +3.15 (+3.87%) USD | NASDAQ | Jan 14, 12:43

View Other Long Term Liabilities (Quarterly) for PTGX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Johnson & Johnson	Upgrade
ADMA Biologics, Inc.	Upgrade
Bristol Myers Squibb Co.	Upgrade
MannKind Corp.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade